Literature DB >> 7496646

Effect of exposure to dothiepin and northiaden in breast milk on child development.

A Buist1, H Janson.   

Abstract

BACKGROUND: This study looks at the outcome of infants exposed to dothiepin in breast milk in an attempt to guide clinicians on the risk-benefit ratio of breast-feeding when on antidepressants.
METHOD: Thirty women, who had had HDRS scores > 15 within the first five years postpartum from the same women's hospital, were assessed with their children 3-5 years postpartum; half had breast-fed while on dothiepin (study group). Thirty-six non-depressed women were also assessed. Rating scales assessed depression, anxiety, self-esteem, personality, social support, marital relationship, child behaviour and temperament. The children were assessed by the McCarthy Scale.
RESULTS: Comparisons of the two depressed groups showed no significant differences on any measures except marital conflict and child behaviour, which were the most disturbed in the study group (P < 0.001). Overall cognitive scores for the children did not differ between the groups. Higher levels of dothiepin and northiaden were associated with higher cognitive scores on subscales (P = 0.02).
CONCLUSIONS: We are cautiously optimistic about the lack of any negative associations between cognitive development and exposure to dothiepin via breast milk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496646     DOI: 10.1192/bjp.167.3.370

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

1.  Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.

Authors:  L Appleby; G Koren; D Sharp
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

2.  Kawasaki disease--a diagnostic challenge.

Authors:  A Harnden
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

Review 3.  Antidepressants and breast-feeding: a review of the literature.

Authors:  S Dodd; A Buist; T R Norman
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 4.  Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus.

Authors:  C McGrath; A Buist; T R Norman
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 5.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 6.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

7.  Postpartum psychiatric disorders : guidelines for management.

Authors:  A Buist
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 8.  Metabolism of tricyclic antidepressants.

Authors:  M V Rudorfer; W Z Potter
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

9.  Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.

Authors:  K F Ilett; L P Hackett; L J Dusci; M J Roberts; J H Kristensen; M Paech; A Groves; P Yapp
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

10.  Distribution and excretion of sertraline and N-desmethylsertraline in human milk.

Authors:  J H Kristensen; K F Ilett; L J Dusci; L P Hackett; P Yapp; R E Wojnar-Horton; M J Roberts; M Paech
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.